FdaApplication
ANDA 205237
Identifiers
- fda_app_no: ANDA205237
Properties
| Property | Value |
|---|---|
| applicant_name | SCIEGEN PHARMACEUTICALS INC |
| application_type | ANDA |
| approval_date | 2022-03-17 |
Products (4)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| LACOSAMIDE | LACOSAMIDE | 150MG | TABLET;ORAL |
| LACOSAMIDE | LACOSAMIDE | 200MG | TABLET;ORAL |
| LACOSAMIDE | LACOSAMIDE | 100MG | TABLET;ORAL |
| LACOSAMIDE | LACOSAMIDE | 50MG | TABLET;ORAL |
4 products